Patel Sheena M, Duchowny Kate A, Kiel Douglas P, Correa-de-Araujo Rosaly, Fielding Roger A, Travison Thomas, Magaziner Jay, Manini Todd, Xue Qian-Li, Newman Anne B, Pencina Karol M, Santanasto Adam J, Bhasin Shalender, Cawthon Peggy M
California Pacific Medical Center, Research Institute, San Francisco, California.
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
J Am Geriatr Soc. 2020 Jul;68(7):1438-1444. doi: 10.1111/jgs.16419. Epub 2020 Jul 7.
BACKGROUND/OBJECTIVES: The extent to which the prevalence of muscle weakness in the US population varies by different putative grip strength constructs developed by the Sarcopenia Definitions and Outcomes Consortium (SDOC) has not been described.
Cross-sectional analysis.
Two nationally representative cohorts-2010 and 2012 waves of the Health and Retirement Survey and round 1 (2011) of the National Health and Aging Trends Survey.
Adults aged 65 years and older (n = 12,984) were included in these analyses.
We analyzed three constructs of muscle weakness developed by the SDOC, and found to be associated with mobility disability for men and women, respectively: absolute grip strength (<35.5 kg and 20 kg); grip strength standardized to body mass index (<1.05 kg/kg/m² and 0.79 kg/kg/m²); and grip strength standardized to weight (<0.45 kg/kg and 0.337 kg/kg). We estimated the prevalence of muscle weakness defined by each of these constructs in the overall older US population, and by age, sex, race, and ethnicity. We also estimated the sensitivity and specificity of each of the grip strength constructs to discriminate slowness (gait speed <0.8 m/s) in these samples.
The prevalence of muscle weakness ranged from 23% to 61% for men and from 30% to 66% for women, depending on the construct used. There was substantial variation in the prevalence of muscle weakness by race and ethnicity. The sensitivity and specificity of these measures for discriminating slowness varied widely, ranging from 0.30 to 0.92 (sensitivity) and from 0.17 to 0.88 (specificity).
The prevalence of muscle weakness, defined by the putative SDOC grip strength constructs, depends on the construct of weakness used. J Am Geriatr Soc 68:1438-1444, 2020.
背景/目的:美国人群中肌肉无力的患病率因肌肉减少症定义与结局联盟(SDOC)制定的不同假定握力指标而异的程度尚未得到描述。
横断面分析。
两项具有全国代表性的队列研究——2010年和2012年的健康与退休调查以及2011年第一轮的国民健康与老龄化趋势调查。
这些分析纳入了65岁及以上的成年人(n = 12,984)。
我们分析了SDOC制定的三种肌肉无力指标,发现它们分别与男性和女性的行动能力障碍相关:绝对握力(<35.5千克和20千克);根据体重指数标准化的握力(<1.05千克/千克/平方米和0.79千克/千克/平方米);以及根据体重标准化的握力(<0.45千克/千克和0.337千克/千克)。我们估计了这些指标所定义的肌肉无力在美国老年人群总体中的患病率,以及按年龄、性别、种族和族裔划分的患病率。我们还估计了每个握力指标在这些样本中区分行动迟缓(步速<0.8米/秒)的敏感性和特异性。
根据所使用的指标,男性肌肉无力的患病率在23%至61%之间,女性在30%至66%之间。肌肉无力的患病率在种族和族裔方面存在很大差异。这些指标区分行动迟缓的敏感性和特异性差异很大,范围从0.30至0.92(敏感性)和从0.17至0.88(特异性)。
由假定的SDOC握力指标定义的肌肉无力患病率取决于所使用的无力指标。《美国老年医学会杂志》2020年;68:1438 - 1444。